Over two million Americans use products containing Reglan. This popular drug, also sold in the generic form of metoclopramide, is commonly used in treating patients suffering from gastrointestinal problems. The Food and Drug Administration and other medical sources have linked Reglan to tardive dyskinesia, a central nervous system disorder that causes involuntary, repetitive movements of the body that may become permanent. These repetitive movements can become a permanent side effect from taking Reglan even after the drug is stopped. The effects of taking Reglan can be devastating, causing severe mental, emotional, physical and social affliction.
On February 26, 2009 the FDA required a black box warning to be placed on Reglan’s drug labels to make both patients and doctors aware of the increased risk of developing tardive dyskinesia from prolonged Reglan use. The black box is the highest warning the FDA can require for a drug and is only mandated in the most serious of cases.
Reglan is typically used to treat gastroesophageal reflux disease (GERD), vomiting and nausea, heartburn, reflux and gastroparesis. The FDA approved Reglan for only short-term use in adults of 12 weeks or less. When Reglan is used for longer than a 12-week consecutive period or in higher doses, the likelihood of developing tardive dyskinesia increases dramatically. Many doctors were unaware of these effects and FDA’s guidelines became increasingly overlooked and understated. Even with the inadequate warnings, many prescriptions continue to be written by doctors for intervals beyond the recommended 12-week period.
Symptoms of tardive dyskinesia include:
- Lip smacking
- Neck pulls
- Blinking and rapid eye movement
- Tongue protrusion
- Involuntary facial gestures
- Involuntary and impaired finger movements
- Difficulty breathing, swallowing, talking and walking
Currently there is no known cure for Reglan-induced tardive dyskinesia, and the treatments to manage tardive dyskinesia are still in the infant stages of widespread use.
Our Reglan lawyers continue to investigate potential Reglan lawsuits and Reglan claims of those who suffer from movement disorder side effects such as tardive dyskinesia. If you or a loved one has suffered from side effects such as tardive dyskinesia after taking Reglan, you may want to call our Reglan lawyers to help protect your legal interests.
FDA Video: Warning on Metoclopramide (Reglan)
With the devastating impact Reglan has on some patients, there have been a number of Reglan lawsuits filed. Over 600 reglan lawsuits have been filed to date. Below is a chart of the mostly commonly seen defendants and the national drug code that corresponds with their reglan/metoclopramide products.
Defendant Manufacturers: National Drug CODE (NDC):
|Major Pharm, Inc.||00904|
|Pharmaceutical Assoc Inc. Div. Beach Prod.||00121|
|Raubaxy Ph. Inc||63304|
|Wyeth (Richmond Div)||00031|
|Morton Pharmaceutical Company Inc.||53489|
|United Research Laboratories Inc.||00677|
|Anip Acquisition Co.||62559|
|Apothecon (terminated NDC 7/01/07)||62269|
|MedPoint (distributor for Watson)||59122-2910|
|Duramed sub Barr||51285|
Many of these drug manufacturers have been named in lawsuits filed by Childers, Schlueter & Smith, LLC regarding the dangers of Reglan.
For more resources on tardive dyskinesia, check the following out:
The Bachmann-Strauss Dystonia & Parkinson Foundation, Inc.
Dystonia Spasmodic Torticollis
The Movement Disorder Society
The effects of Reglan/metoclopramide can have a great effect on a person’s life, severely altering it for the worse. Our Reglan lawyers are filing Reglan lawsuits in Georgia and other U.S. states on behalf of those suffering from tardive dyskinesia and other known movement disorders. If you or a loved one has questions about your rights or any of these conditions, please contact our Reglan Attorneys now to see how we can help. All inquires are kept confidential.